MENU

CMRX Chimerix Forecast, Technical & Fundamental Analysis

a developer of novel oral antiviral therapeutics

Industry Biotechnology
CMRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CMRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CMRX is expected to report earnings to rise 6.09% to -24 cents per share on October 31

Chimerix CMRX Stock Earnings Reports
Q3'24
Est.
$-0.24
Q2'24
Est.
$-0.23
Q1'24
Missed
by $0.04
Q4'23
Beat
by $0.04
Q3'23
Missed
by $0.04
The last earnings report on August 13 showed earnings per share of -23 cents, meeting the estimate of -23 cents. With 181.51K shares outstanding, the current market capitalization sits at 79.99M.
A.I. Advisor
published General Information

General Information

a developer of novel oral antiviral therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2505 Meridian Parkway
Phone
+1 919 806-1074
Employees
72
Web
https://www.chimerix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

CMRX and Stocks

Correlation & Price change

A.I.dvisor tells us that CMRX and DNA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMRX and DNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
-7.01%
DNA - CMRX
30%
Poorly correlated
-8.82%
KRYS - CMRX
28%
Poorly correlated
-4.27%
STRO - CMRX
27%
Poorly correlated
-4.38%
BLRX - CMRX
27%
Poorly correlated
-2.13%
ALLO - CMRX
27%
Poorly correlated
-4.56%
More

Groups containing CMRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
-7.01%
therapeutics
theme (57 stocks)
22%
Poorly correlated
+20.54%
drugs
theme (265 stocks)
21%
Poorly correlated
+5.37%
biotechnology
theme (248 stocks)
17%
Poorly correlated
+5.56%
oral products
theme (5 stocks)
14%
Poorly correlated
-0.85%